Abstract
Purpose
Subthreshold micropulse laser irradiation has been used for the treatment of retinal edema; however, there are few reports about the mechanism of its therapeutic effect. In this study, we compared threshold short pulse and subthreshold micropulse laser irradiation in mice and investigated their mechanism.
Methods
Nine to 12-week-old male C57BL/6J mice were used in this study. After general anesthesia, threshold short pulse or subthreshold micropulse laser irradiation was performed on the right eye using IQ577. Enucleation was performed 24 h after the laser irradiation, and histological and gene expression analyses were carried out.
Results
Coagulation spots and atrophy of the retinal pigment epithelium were observed after threshold short pulse laser irradiation but not after subthreshold micropulse laser irradiation. Twenty-four hours after laser, aquaporin (AQP) 1, 2, 7, and 11 levels were significantly elevated by 1.7- to 3-fold in the threshold short pulse laser group compared with non-treated control group. AQP 3 was increased significantly and prominently by 100-fold. VEGF-A and VEGFR2 were upregulated 1.5- and 2.3-fold, respectively. In the subthreshold micropulse laser group, AQP 3 was increased by 6-fold compared with the non-treated control group. Angiopoietin-1 and the adrenomedullin (AM) receptor CLR were decreased by 0.6-fold and 0.5-fold, respectively.
Conclusion
Threshold short pulse laser irradiation caused retinal damage and prominent changes in the expression of various genes. Contrarily, subthreshold micropulse laser irradiation did not induce retinal damage; it upregulated AQP 3, which might have improved retinal edema by drainage of subretinal fluid.
Similar content being viewed by others
References
Meyer-Schwickerath G (1959) Light coagulation. Buech Augenarzt 33:1–96
The Diabetic Retinopathy Study Research Group (1976) Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 81:383–396. https://doi.org/10.1016/0002-9394(76)90292-0
Early Treatment Diabetic Retinopathy Study research group (1985) Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Arch Ophthalmol 103:1796–1806
Robertson DM, Ilstrup D (1983) Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol 95:457–466. https://doi.org/10.1016/0002-9394(83)90265-9
Ficker L, Vafidis G, While A, Leaver P (1988) Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 72:829–834. https://doi.org/10.1136/bjo.72.11.829
The Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 98:271–282. https://doi.org/10.1016/0002-9394(84)90316-7
Wilkinson CP (2000) Evidence-based analysis of prophylactic treatment of asymptomatic retinal breaks and lattice degeneration. Ophthalmology 107:12–15; discussion 15-18. https://doi.org/10.1016/s0161-6420(99)00049-4
Early Treatment Diabetic Retinopathy Study research group (1981) Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of diabetic retinopathy study (DRS) findings, DRS report number 8. Ophthalmology 88:583–600
Early Treatment Diabetic Retinopathy Study research group (1991) Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 98(5 Suppl):766–785
Lavinsky D, Wang J, Huie P, Dalal R, Lee SJ, Lee DY, Palanker D (2016) Nondamaging retinal laser therapy: rationale and applications to the macula. Invest Ophthalmol Vis Sci 57:2488–2500. https://doi.org/10.1167/iovs.15-18981
Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME (2008) Vascular endothelial growth factor in eye disease. Prog Retin Eye Res 27:331–371. https://doi.org/10.1016/j.preteyeres.2008.05.001
Al-Shabrawey M, Elsherbiny M, Nussbaum J, Othman A, Megyerdi S, Tawfik A (2013) Targeting neovascularization in ischemic retinopathy: recent advances. Expert Rev Ophthalmol 8:267–286. https://doi.org/10.1586/eop.13.17
Semeraro F, Cancarini A, dell’Omo R, Rezzola S, Romano MR, Costagliola C (2015) Diabetic retinopathy: vascular and inflammatory disease. J Diabetes Res 2015:582060. https://doi.org/10.1155/2015/582060
Budzynski E, Smith JH, Bryar P, Birol G, Linsenmeier RA (2008) Effects of photocoagulation on intraretinal PO2 in cat. Invest Ophthalmol Vis Sci 49:380–389. https://doi.org/10.1167/iovs.07-0065
Scholz P, Altay L, Fauser S (2017) A review of subthreshold micropulse laser for treatment of macular disorders. Adv Ther 34:1528–1555. https://doi.org/10.1007/s12325-017-0559-y
Gawecki M (2019) Micropulse laser treatment of retinal diseases. J Clin Med 8(2). https://doi.org/10.3390/jcm8020242
Aquino MC, Lim D, Chew PT (2018) Micropulse P3 (MP3) laser for glaucoma: an nnovative therapy. J Curr Glaucoma Pract 12:51–52. https://doi.org/10.5005/jp-journals-10008-1244
Luttrull JK, Dorin G (2012) Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review. Curr Diabetes Rev 8:274–284
Inagaki K, Shuo T, Katakura K, Ebihara N, Murakami A, Ohkoshi K (2015) Sublethal photothermal stimulation with a micropulse laser induces heat shock protein expression in ARPE-19 cells. J Ophthalmol 2015:729792. https://doi.org/10.1155/2015/729792
Li Z, Song Y, Chen X, Chen Z, Ding Q (2015) Biological modulation of mouse RPE cells in response to subthreshold diode icropulse laser treatment. Cell Biochem Biophys 73:545–552. https://doi.org/10.1007/s12013-015-0675-8
Itaya M, Sakurai E, Nozaki M, Yamada K, Yamasaki S, Asai K, Ogura Y (2007) Upregulation of VEGF in murine retina via monocyte recruitment after retinal scatter laser photocoagulation. Invest Ophthalmol Vis Sci 48:5677–5683. https://doi.org/10.1167/iovs.07-0156
Virgili G, Michelessi M, Parodi MB, Bacherini D, Evans JR (2015) Laser treatment of drusen to prevent progression to advanced age-related macular degeneration. Cochrane Database Syst Rev 10:Cd006537. https://doi.org/10.1002/14651858.CD006537.pub3
Mahalka AK, Code C, Rezaijahromi B, Kirkegaard T, Jäättelä M, Kinnunen PKJ (2011) Activation of phospholipase A2 by Hsp70 in vitro. Biochim Biophys Acta Biomembr 1808:2569–2572. https://doi.org/10.1016/j.bbamem.2011.06.002
Hollborn M, Ulbricht E, Reichenbach A, Wiedemann P, Bringmann A, Kohen L (2012) Transcriptional regulation of aquaporin-3 in human retinal pigment epithelial cells. Mol Biol Rep 39:7949–7956. https://doi.org/10.1007/s11033-012-1640-x
Hirabayashi K, Tanaka M, Imai A, Toriyama Y, Iesato Y, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Kawate H, Tanaka M, Dai K, Cui N, Wei Y, Nakamura K, Iida S, Matsui S, Yamauchi A, Murata T, Shindo T (2019) Development of a novel model of central retinal vascular occlusion and the therapeutic potential of the adrenomedullin-receptor activity-modifying protein 2 system. Am J Pathol 189:449–466. https://doi.org/10.1016/j.ajpath.2018.10.021
Imai A, Toriyama Y, Iesato Y, Hirabayashi K, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Kawate H, Tanaka M, Liu T, Xian X, Zhai L, Dai K, Tanimura K, Liu T, Cui N, Yamauchi A, Murata T, Shindo T (2017) Adrenomedullin suppresses vascular endothelial growth factor-induced vascular hyperpermeability and inflammation in retinopathy. Am J Pathol 187:999–1015. https://doi.org/10.1016/j.ajpath.2017.01.014
Vujosevic S, Gatti V, Muraca A, Brambilla M, Villani E, Nucci P, Rossetti L, De Cillaʼ S (2020) Optical coherence tomography angiography changes after subthreshold micropulse yellow laser in diabetic macular edema. Retina 40:312–321. https://doi.org/10.1097/IAE.0000000000002383
Iandiev I, Pannicke T, Reichel MB, Wiedemann P, Reichenbach A, Bringmann A (2005) Expression of aquaporin-1 immunoreactivity by photoreceptor cells in the mouse retina. Neurosci Lett 388:96–99. https://doi.org/10.1016/j.neulet.2005.06.046
Funding
This study was supported by Grants-in-Aid for Scientific Research (KAKENHI), Core Research for Evolutionary Science and Technology (CREST) of the Japan Science and Technology Agency (JST), and the Japan Agency for Medical Research and Development (AMED), and research grants from Bristol-Myers Squibb Company, the Japan Foundation for Applied Enzymology, the Naito Foundation, the Public Foundation of Chubu Science and Technology Center, Yamaguchi Endocrine Research Foundation, Hoyu Science Foundation, Takahashi Industrial and Economic Research Foundation, Akaeda Medical Research Foundation, Shinshu Public Utility Foundation for Promotion of Medial Sciences, NOVARTIS Foundation (Japan) for the Promotion of Science grant, and Japan Heart Foundation to TS.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation and data collection and analysis were performed by KH, SK, and MT. The first draft of the manuscript was written by KH, and all authors commented on previous versions of the manuscript. All authors read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethical approval
All animal handling procedures were in accordance with a protocol approved by the Ethics Committee of Shinshu University School of Medicine No.280079. All experiments were performed in accordance with the Association for Research in Vision and Ophthalmology’s Statement for the Use of Animals in Ophthalmic and Vision Research and our institutional guidelines.
Conflict of interest
TM received financial support from Novartis. All other authors report that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hirabayashi, K., Kakihara, S., Tanaka, M. et al. Investigation of the therapeutic mechanism of subthreshold micropulse laser irradiation in retina. Graefes Arch Clin Exp Ophthalmol 258, 1039–1047 (2020). https://doi.org/10.1007/s00417-020-04638-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-020-04638-3